đź“Š Evidence-Based Reference
calaview etafilcon a soft hydrophilic contact lens for daily wear
Innova Vision
Summary: Calaview etafilcon A is a soft hydrophilic contact lens for daily wear, primarily used for vision correction. Key evidence highlights its improved wettability and antimicrobial properties.
FDA Clearance Information
Pathway
510K
Number
K073060 ↗
Decision Date
November 29, 2007
Product Code
MVN
Device Class
Class 2
Evidence
419 studies
The Calaview etafilcon A contact lens was cleared by the FDA via the 510(k) pathway on November 29, 2007. It is manufactured by Innova Vision and classified as a Class 2 medical device.
What It Is
The Calaview etafilcon A is a soft hydrophilic contact lens designed for daily wear. It is intended for vision correction and incorporates materials to enhance comfort and reduce microbial infection risk.
Clinical Applications
Commonly used in patients requiring vision correction, the Calaview etafilcon A lens is suitable for daily wear. It is particularly beneficial for individuals seeking enhanced comfort and antimicrobial protection.
Evidence Summary
The literature includes 10 studies, comprising randomized controlled trials and retrospective reviews, conducted between 2016 and 2025. These studies explore various aspects of lens performance, safety, and user satisfaction.
Reported Outcomes
Published studies report that the Calaview etafilcon A lenses improve wettability and maintain antimicrobial properties. User satisfaction is influenced by factors such as comfort and vision quality. The lenses are also associated with stable tear film and corneal thickness during wear.
Safety Profile
Reported complications include ocular surface temperature changes and potential adverse events in children, as observed in retrospective reviews. Overall, the lenses are considered safe for daily use with minimal adverse effects.
Evidence Limitations
Current evidence is limited by the variability in study designs and sample sizes. Further research is needed to explore long-term outcomes and the impact of lens materials on ocular health.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Calaview etafilcon A?
The Calaview etafilcon A is indicated for daily wear in vision correction, with added benefits of improved comfort and antimicrobial properties.
What outcomes have been reported in clinical studies?
Studies report improved wettability, antimicrobial properties, and user satisfaction related to comfort and vision quality.
What complications have been reported?
Safety data indicate minimal complications, with some reports of ocular surface temperature changes and rare adverse events in children.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.